MINNEAPOLIS, Sept. 10, 2014 /PRNewswire/ -- Uroplasty, Inc.
(NASDAQ: UPI) a medical device company that develops, manufactures
and markets innovative proprietary products for the treatment of
voiding dysfunctions, today announced that it will participate in
the 5th Annual Craig-Hallum Alpha Select Conference on
Thursday, September 18.
Brett Reynolds, SVP and CFO, and
Darin Hammers, SVP of Global Sales
and Marketing, will present at 12:00pm
ET and meet with investors one on one at the conference at
the Convene Conference Center in New York
City. Attendance at the conference is by invitation only. A
live webcast of the presentation with accompanying slides will be
broadcast via the Internet. Those interested in joining the webcast
may access it through Uroplasty's website at www.uroplasty.com. An
archived replay of the presentation will be available for 90 days
following the event.
About Uroplasty, Inc.
Uroplasty, Inc., headquartered
in Minnetonka, Minnesota, with
wholly-owned subsidiaries in The
Netherlands and the United
Kingdom, is a global medical device company that develops,
manufactures and markets innovative proprietary products for the
treatment of voiding dysfunctions. Our focus is the continued
commercialization of our Urgent® PC Neuromodulation System, the
only commercially available, FDA-cleared system that delivers
percutaneous tibial nerve stimulation (PTNS) for the office-based
treatment of overactive bladder (OAB). OAB is a chronic condition
that affects approximately 42 million U.S. adults. The
symptoms include urinary urgency, frequency and urge
incontinence. We also offer Macroplastique®, an injectable
urethral bulking agent for the treatment of adult female stress
urinary incontinence primarily due to intrinsic sphincter
deficiency. For more information on the company and its products,
please visit Uroplasty, Inc. at www.uroplasty.com.
For Further Information:
Uroplasty, Inc.
Brett Reynolds, SVP and CFO
952.426.6152
EVC Group
Doug Sherk (Investors)/Janine McCargo (Business Media)
415.652.9100/646.688.0245
SOURCE Uroplasty, Inc.